List of Excipients in API vismodegib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing vismodegib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genentech Inc | ERIVEDGE | vismodegib | 50242-140 | CELLULOSE, MICROCRYSTALLINE | 2028-11-11 |
| Genentech Inc | ERIVEDGE | vismodegib | 50242-140 | FERRIC OXIDE RED | 2028-11-11 |
| Genentech Inc | ERIVEDGE | vismodegib | 50242-140 | FERROSOFERRIC OXIDE | 2028-11-11 |
| Genentech Inc | ERIVEDGE | vismodegib | 50242-140 | GELATIN | 2028-11-11 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for vismodegib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
vismodegib drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
vismodegib drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
vismodegib drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
vismodegib drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
vismodegib drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
vismodegib drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
vismodegib drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
vismodegib drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
vismodegib drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
vismodegib drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
vismodegib drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | vismodegib | 50242-140 |
| >Company | >Ingredient | >NDC |
vismodegib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
